{"title":"Correction to “Successful Treatment of Pyoderma Gangrenosum With Guselkumab”","authors":"","doi":"10.1002/jvc2.70031","DOIUrl":null,"url":null,"abstract":"<p>S. Botvid, C. Zachariae, Skov, L., and J. Ferløv Schwensen. “Successful Treatment of Pyoderma Gangrenosum With Guselkumab.” <i>JEADV Clinical Practice</i> 4, no. 1 (2025): 229. https://doi.org/10.1002/jvc2.522</p><p>Under the subheading “Case Report” of Case 1, line 8–9, the current text states: “Starting in November 2022, the patient was treated with injections (off-label) of guselkumab 400 mg, every sixth week.”</p><p>However, the correct dosage should be “<b>100 mg,</b> every sixth week” rather than 400 mg.</p><p>We sincerely apologize for this error.</p>","PeriodicalId":94325,"journal":{"name":"JEADV clinical practice","volume":"4 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jvc2.70031","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JEADV clinical practice","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jvc2.70031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
S. Botvid, C. Zachariae, Skov, L., and J. Ferløv Schwensen. “Successful Treatment of Pyoderma Gangrenosum With Guselkumab.” JEADV Clinical Practice 4, no. 1 (2025): 229. https://doi.org/10.1002/jvc2.522
Under the subheading “Case Report” of Case 1, line 8–9, the current text states: “Starting in November 2022, the patient was treated with injections (off-label) of guselkumab 400 mg, every sixth week.”
However, the correct dosage should be “100 mg, every sixth week” rather than 400 mg.
S. Botvid， C. Zachariae, Skov， L. Ferløv Schwensen。Guselkumab成功治疗坏疽性脓皮病《JEADV临床实践》第4期。1(2025): 229。https://doi.org/10.1002/jvc2.522Under病例1的副标题“病例报告”，第8-9行，当前文本指出：“从2022年11月开始，患者接受注射（标签外）400 mg的guselkumab治疗，每六周一次。”然而，正确的剂量应该是“每六周100毫克”，而不是400毫克。我们真诚地为这个错误道歉。
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
